The Nature and Influence of Pharmaceutical Industry Involvement in Asthma Trials

Kenneth Bond; Carol Spooner; Lisa Tjosvold; Catherine Lemière; Brian H Rowe

doi:10.1155/2012/890457

Canadian Respiratory Journal (Jan 2012)

The Nature and Influence of Pharmaceutical Industry Involvement in Asthma Trials

Kenneth Bond,
Carol Spooner,
Lisa Tjosvold,
Catherine Lemière,
Brian H Rowe

Affiliations

Kenneth Bond: Institute for Health Economics, University of Alberta, Canada
Carol Spooner: Alberta Research Centre for Health Evidence, University of Alberta, Canada
Lisa Tjosvold: Alliance for Canadian Health Outcomes Research on Diabetes, School of Public Health, University of Alberta, Edmonton, Alberta, Canada
Catherine Lemière: Sacre-Coeur Hospital and Department of Medicine, University of Montreal, Montreal, Quebec, Canada
Brian H Rowe: Department of Emergency Medicine, University of Alberta, Edmonton, Alberta, Canada

DOI: https://doi.org/10.1155/2012/890457
Journal volume & issue: Vol. 19, no. 4
pp. 267 – 271

Abstract

Read online

BACKGROUND: Pharmaceutical industry-sponsored research has been shown to be biased toward reporting positive results. Frequent industry participation in trials assessing the efficacy of inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination treatment makes assessing industry influence difficult and warrants an assessment of specific potential publication bias in this area.

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Hindawi Limited
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal